<DOC>
	<DOCNO>NCT02748460</DOCNO>
	<brief_summary>This multi-centre , multinational , prospective , non-interventional study female diagnosis moderate severe uterine fibroid , treatment Esmya long term manner plan , subject previously expose UPA long term Phase III study . It plan enrol approximately 1,500 patient . Consecutive , eligible , patient invite enrol approximately 100-150 European Union ( EU ) clinical practice site approximately 15 country . Patients follow observation period 60 month ( 5 year ) treatment start . Investigators manage treat patient accord standard medical practice . The specific objective study assess long term safety , include endometrial safety , Esmya standard medical practice prescription pattern Esmya standard medical practice . The exploratory objective ass patient ' quality life long-term treatment setting .</brief_summary>
	<brief_title>Non-interventional Study Evaluate Long Term Safety , Prescription Management Patterns Esmya Long Term Setting</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Adult woman reproductive age diagnosis moderate severe symptom uterine fibroid treatment Esmya long term manner ( least 2 course ) , plan subject expose UPA 5 10 mg long term Phase III trial PGL09027 ( PEARL III extension , include patient ( PEARL extension 2 ) ) PGL11006 ( PEARL IV ) , Patient willing able attend visit schedule treat physician regular followup , provide require medical data , Patient personally sign date informed consent document indicate informed pertinent aspect study . Exclusion criterion : Patient prescribe Esmya preoperative treatment Patient use investigational drug/therapy discontinue use investigational drug/therapy within 30 day prior study enrolment , Patient hypersensitivity active substance Esmya one excipients , Not applicable long term phase III previous subject plan receive Esmya study : Patient pregnant plan become pregnant within next 12 month treatment start , Patient breastfeeding , Patient genital bleed unknown aetiology due uterine fibroid , Patient diagnose uterine , cervical , ovarian breast cancer .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>